• 대한병리학회지
• /
• 제52권6호
• /
• pp.404-410
• /
• 2018

Background: Fine-needle aspiration cytology serves as a safe, economical tool in evaluating thyroid nodules. However, about 30% of the samples are categorized as indeterminate. Hence, many immunocytochemistry markers have been studied, but there has not been a single outstanding marker. We studied the efficacy of CD56 with human bone marrow endothelial cell marker-1 (HBME-1) in diagnosis in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) category III. Methods: We reviewed ThinPrep liquid-based cytology (LBC) samples with Papanicolaou stain from July 1 to December 31, 2016 (2,195 cases) and selected TBSRTC category III cases (n=363). Twenty-six cases were histologically confirmed as benign (six cases, 23%) or malignant (20 cases, 77%); we stained 26 LBC slides with HBME-1 and CD56 through the cell transfer method. For evaluation of reactivity of immunocytochemistry, we chose atypical follicular cell clusters. Results: CD56 was not reactive in 18 of 20 cases (90%) of malignant nodules and showed cytoplasmic positivity in five of six cases (83%) of benign nodules. CD56 showed high sensitivity (90.0%) and relatively low specificity (83.3%) in detecting malignancy (p=.004). HBME-1 was reactive in 17 of 20 cases (85%) of malignant nodules and was not reactive in five of six cases (83%) of benign nodules. HBME-1 showed slightly lower sensitivity (85.0%) than CD56. The specificity in detecting malignancy by HBME-1 was similar to that of CD56 (83.3%, p=.008). CD56 and HBME-1 tests combined showed lower sensitivity (75.0% vs 90%) and higher specificity (93.8% vs 83.3%) in detecting malignancy compared to using CD56 alone. Conclusions: Using CD56 alone showed relatively low specificity despite high sensitivity for detecting malignancy. Combining CD56 with HBME-1 could increase the specificity. Thus, we suggest that CD56 could be a useful preoperative marker for differential diagnosis of TBSRTC category III samples.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권16호
• /
• pp.6923-6928
• /
• 2015

Background: Early detection of various kinds of cancers nowadays is needed including colorectal cancer due to the highly significant effects in improving cancer treatment. The aim of this study was to evaluate the potential value of adiponectin, visfatin and resistin as early biomarkers for colorectal cancer patients. Materials and Methods: Serum levels of adiponectin, visfatin and resistin were measured by a sandwich-enzyme-linked (ELISA) assay technique in 114 serum samples comprising 34 patients with colorectal cancer (CRC), 27 with colonic polyps (CP), 24 with inflammatory bowel disease (IBD) and 29 healthy controls. The diagnostic accuracy of each serum marker was evaluated using receiver-operating characteristic (ROC) curve analysis. Results: The mean concentration of adiponectin was significantly higher in CRC and CP groups than IBD and control groups (P-value <0.05). Also the mean concentration of serum resistin was significantly elevated in the IBD and control groups compared to CRC and CP groups (P-value = 0.014). However, no significant difference was noted in patients of the CRC and CP groups. On the other hand, the mean concentration of visfatin was significantly elevated in CRC and control groups compared to CP and IBD groups (P-value = 0.03). ROC analysis curves for the studied markers revealed that between CRC and IBD groups serum level of adiponectin had a sensitivity of 76.7% and a specificity of 76% at a cut off value of 3940, +LR being 3.2 and -LR 0.31 with AUC 0.852, while serum level of adiponectin between CP and IBD had a sensitivity of 77.8% and a specificity of 75% at a cut off value of 3300, with +LR=3.11 and -LR = 0.3 with AUC 0.852. On the other hand the serum level of visfatin between CRC and CP groups had a sensitivity of 65.5% and a specificity of 66.7 at a cut off value of 2.4, +LR being 1.67 and -LR 0.52 with AUC 0.698. Also the serum level of resistin had a sensitivity of 62.5% and a specificity of 70.3% at a cut off value of 24500, with +LR=2.1 and -LR = 0.53 with AUC 0.685 between control and other groups. On the other hand by comparing control vs CP groups resistin had a sensitivity of 81.8% and a specificity of 70.8% at a cut off value of 17700, with +LR=2.8 and -LR = 0.26 with AUC 0.763 while visfatin had a sensitivity of 68.2% and a specificity of 70.8% at a cut off value of 2.7, with +LR=2.34 and -LR = 0.0.45 with AUC 0.812. Conclusions: These findings support potential roles of adiponectin, visfatin and resistin in early detection of CRC and discrimination of different groups of CRC, CP or IBD patients from normal healthy individuals.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권17호
• /
• pp.7061-7064
• /
• 2014

Background: To assess the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of intraoperative gross examination (IGE) of uterine specimens in determining deep myometrial invasion and cervical invasion compared to final histology. Materials and Methods: The clinical, surgical and histological data of all FIGO stage I-II endometrial cancer (EC) patients who had primary surgery were reviewed. Results of the IGE for myometrial invasion and cervical invasion were compared to the final histology. The sensitivity, specificity, PPV, NPV, and accuracy of the IGE in determining deep myometrial invasion and cervical invasion were calculated. Association between clinico-pathological factors and discrepancy between IGE and final histology in the determination of myometrial invasion was also assessed. A p-value of <0.05 was considered significant. Results: From January 2007 to December 2012, 179 patients diagnosed with clinical stage I-II endometrial cancer underwent surgical staging. The sensitivity and specificity of IGE in detecting deep myometrial invasion were 42.4% and 90.0%, respectively, and the PPV and NPV were 67.6% and 76.1%. The overall accuracy of IGE was 74.3%. The sensitivity and specificity of IGE in identifying cervical invasion were 28.6% and 97.5%, respectively, while the PPV and NPV were 60.0% and 91.1%. The overall accuracy of IGE was 89.4%. Conclusions: The sensitivity of IGE for detecting deep myometrial invasion and cervical invasion in early-stage EC is too low to be used alone. Alternative methods including intraoperative frozen section analysis, preoperative three dimensional ultrasound, and preoperative magnetic resonance imaging should be strongly considered.

• Clinical and Experimental Pediatrics
• /
• 제45권4호
• /
• pp.482-488
• /
• 2002

목 적 : 신속 요소분해효소 검사는 H. pylori 감염 진단에 있어서 위내시경 검사가 시행되는 병원에서 우선적으로 시행되는 검사이다. 또한 위내시경상 검사상 결절성 위염을 보이는 경우 H. pylori 감염 빈도 가 높은 것으로 알려져 있다. 본 연구에서는 위내시경 소견인 결절성 위염의 진단적 의의와 신속 요소분해 효소 검사인 CLO 및 HpKit 검사의 양성 반응 시간별 검출률을 전향적으로 비교 분석하였다. 방 법: 1999년 7월부터 2000년 5월까지 연세대학교 세브란스병원 소아과에서 상복부 동통을 주소로 위내시경 검사를 시행받은 환아 212례를 대상으로 위전정부, 위체부에서 각각 3회씩 조직 생검을 시행하였고 각각 1조각씩 CLO 검사, HpKit 검사 및 조직 검사에 이용하였다. CLO 및 HpKit 검사는 생검조직의 양성 반응 시간을 각각 15분, 30분, 1시간, 2시간, 3시간, 24시간에 따라 나누어 판독하였고, 24시간 이후는 CLO 검사의 경우 6일째까지, HpKit 검사의 경우 5일째까지 판독하였다. 생검 조직의 Hematoxylineeosin 염색 또는 Alcian-yellow 염색을 기준지표로 하여 결절성 위염, CLO 및 HpKit 검사의 예민도, 특이도, 양성기대치 및 음성기대치를 구하였다. 결 과: 일반적 판정 기준 시간인 3시간째 판정한 CLO 검사의 진단적 예민도는 68.4%, 특이도는 100%였고, HpKit 검사는 위전정부 및 위체부에서 시행한 경우 진단 예민도는 모두 65.8%, 특이도는 100%였으며, CLO 및 HpKit 검사의 예민도와 특이도 사이에 유의한 차이는 없었다(P>0.05). CLO 검사와 HpKit 검사에서 검체와의 반응 후 시간 경과에 따른 양성률은 CLO 검사의 경우 24시간 경과시에는 예민도와 특이도가 각각 73.7% 및 99.4%로 특이도에 큰 변화 없이 예민도가 점차 증가하였고, 144시간(6일)째에도 특이도는 94.8%로 다소 감소하였으나 예민도는 89.5%로 3시간이나 24시간째와 비교하여 현저히 높아짐을 알 수 있었다. HpKit 검사는 위전정부의 경우(HpKit-A) 24시간 경과시 예민도는 68.4%로 3시간 경과시에 비하여 3% 정도 증가하였으나 특이도는 91.4%로 9% 정도 감소하였고, 120시간(5일) 경과시는 예민도는 86.8%로 증가하였으나 특이도는 59.2%로 현저히 감소하였다. 위체부의 경우(HpKit-B) 24시간 경과시 예민도는 3시간 경과시에 비하여 65.8%로 변화가 없었으나 특이도는 97.1%로 3% 정도 감소하였고, 120시간(5일) 경과시는 예민도는 84.2%로 증가하였으나 특이도는 77.0%로 현저히 감소하였다. 또한 24시간 경과시 위전정부와 위체부의 예민도는 각각 68.4% 및 65.8%로 비슷하였으나 특이도는 각각 91.4% 및 97.1%로 위체부의 특이도가 전정부보다 높았다. 내시경 소견상 결절성 위염의 H. pylori 감염의 예민도와 특이도는 각각 78.9% 및 93.7%로 CLO 검사 및 HpKit 검사보다 예민도는 더 높고 특이도는 비슷하였다. 결 론: CLO 검사와 HpKit 검사는 3시간 이내에 신속히 판정을 요구하는 경우 매우 예민하고 특이도가 우수한 검사 방법이나 소아의 경우 3시간째의 예민도가 너무 낮기 때문에 CLO 검사는 6일 지나서 판정함으로서 높은 예민도를 이용할 수 있을 것으로 생각된다. 또한 결절성 위염의 위내시경 소견은 신속 요소분해효소 검사가 유용하지 않을 경우 H. pylori 감염을 진단할 수 있는 좋은 지표가 될 것으로 사료된다.

• International Journal of Advanced Culture Technology
• /
• 제8권4호
• /
• pp.64-76
• /
• 2020

Purpose: Several screening tools have been developed to identify sarcopenia in rural community-dwelling older adults. We aimed to compare the diagnostic accuracy of two such tools, namely the SARC-F and SARC-CalF assessments. Methods: This cross-sectional study on 388 community-dwelling older adults comprised 254 women and 134 men with a mean age of 77.8 ± 6.26 year in Korea. We assessed muscle mass, muscle strength, and physical performance using a bioimpedance analysis device, hydraulic hand dynamometer, and 4 m gait speed test, respectively. Three widely-used diagnostic criteria [the Asian Working Group for Sarcopenia (AWGS), European Working Group on Sarcopenia in Older People, and the International Working Group on Sarcopenia] were applied. Sensitivity and specificity analyses were performed on the SARC-CalF and SARC-F tests. We used receiver-operating characteristic curves and the area under the curves (AUCs) to compare the diagnostic accuracy of the assessments with regard to sarcopenia. Results: An analysis using four sets of diagnostic criteria showed that the prevalence of sarcopenia was 27.6% to 41.0%. Using the AWGS 2019 criteria as a reference standard, the SARC-CalF had a sensitivity of 83.02% and a specificity of 53.71% in the entire study population, whereas the SARC-F had a sensitivity of 79.87% and a specificity of 41.92%. The AUCs for the SARC-CalF and SARC-F tests were 0.725 (95% confidence interval 0.678-0.769) and 0.645 (95% confidence interval 0.595-0.693), respectively (p<001). In the analyses using the other three diagnostic criteria, similarity was also confirmed. Conclusion: SARC-CalF showed better sensitivity than did SARC-F when diagnosing sarcopenia in rural community-dwelling older adults. Further studies are needed to verify this finding in different populations.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권22호
• /
• pp.9865-9869
• /
• 2014

Background: Transthoracic fine needle aspiration (FNA) is one of several methods for establishing tissue diagnosis of lung lesions. Other tissue or cell sources for diagnosis include sputum, endobronchial biopsy, washing and brushing, endobronchial FNA, transthoracic core needle biopsy, biopsy from thoracoscopy or thoracotomy. The purpose of this study was to compare the sensitivity and specificity of FNA and other diagnostic tests in diagnosing lung lesions. Materials and Methods: The population included all patients undergoing FNA for lung lesions at Meir Medical Center from 2006 through 2010. Information regarding additional tissue tests was derived from the electronic archives of the Department of Pathology, patient records and files from the Department of Oncology. Sensitivity, specificity, diagnostic accuracy, and positive and negative predictive values were calculated for each test. Results: FNA was carried out in 245 patients. Malignant tumors were diagnosed in 190 cases (78%). They included adenocarcinoma (43%), squamous cell carcinoma (15%), non-small cell carcinoma, not otherwise specified (19%), neurondocrine tumors (7%), metastases (9%) and lymphoma (3%). The specificity of FNA for lung neoplasms was 100%; sensitivity and diagnostic accuracy were 87%. Conclusions: FNA is the most sensitive procedure for establishing tissue diagnoses of lung cancer. Combination with core needle biopsy increases the sensitivity. Factors related to the lesion (nature, degenerative changes, location) and to performance of all stages of test affect the ability to establish a diagnosis.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권1호
• /
• pp.363-368
• /
• 2014

Determination of the cause of malignant pleural effusions is important for treatment and management, especially in cases of unknown primaries. There are limited biomarkers available for prediction of the cause of malignant pleural effusion in clinical practice. Hence, we evaluated pleural levels of five tumor biomarkers (CEA, AFP, CA125, CA153 and CA199) in predicting the cause of malignant pleural effusion in a retrospective study. Kruskal-Wallis or Mann-Whitney U tests were carried out to compare levels of tumor markers in pleural effusion among different forms of neoplasia - lung squamous cell carcinoma, adenocarcinoma, or small cell carcinoma, mesothelioma, breast cancer, lymphoma/leukemia and miscellaneous. Receiver operator characteristic analysis was performed to evaluate sensitivity and specificity of biomarkers. The Kruskal-Wallis test showed significant differences in levels of pleural effusion CEA (P<0.01), AFP (P<0.01), CA153 (P<0.01) and CA199 (P<0.01), but not CA125 (P>0.05), among the seven groups. Receiver operator characteristic analysis showed that, compared with other four tumor markers, CA153 was the best biomarker in diagnosing malignant pleural effusions of lung adenocarcinoma (area under curve (AUC): 0.838 (95%confidence interval: 0.787, 0.888); cut-off value: 10.2U/ml; sensitivity: 73.2% (64.4-80.8)%, specificity: 85.2% (77.8-90.8)%), lung squamous cell carcinoma (AUC: 0.716 (0.652, 0.780); cut-off value: 14.2U/ml; sensitivity: 57.6% (50.7-64.3)%, specificity: 91.2% (76.3-98.0)%), and small-cell lung cancer (AUC: 0.812 (0.740, 0.884); cut-off value: 9.7U/ml; sensitivity: 61.5% (55.0-67.8)%, specificity: 94.1% (71.2-99.0)%); CEA was the best biomarker in diagnosing MPEs of mesothelioma (AUC: 0.726 (0.593, 0.858); cut-off value: 1.43ng/ml; sensitivity: 83.7% (78.3-88.2)%, specificity: 61.1% (35.8-82.6)%) and lymphoma/leukemia (AUC: 0.923 (0.872, 0.974); cut-off value: 1.71ng/ml; sensitivity: 82.8% (77.4-87.3)%, specificity: 92.3% (63.9-98.7)%). Thus CA153 and CEA appear to be good biomarkers in diagnosing different causes of malignant pleural effusion. Our findings implied that the two tumor markers may improve the diagnosis and treatment for effusions of unknown primaries.

• 대한소아치과학회지
• /
• 제33권4호
• /
• pp.615-623
• /
• 2006

본 연구는 LED 형광법을 이용하여 각 개인의 우식활성도를 측정할 수 있는지를 규명하기 위해 $6{\sim}7$세의 아동 55명을 대상으로 치아의 순면과 협면에 LED 광을 조사하고 특수 필터를 사용하여 초기 치아우식증이 관찰되는 치아의 수와 우식의 크기, 위치 등을 기록하고, 이와 같은 초기 치아우식증의 수를 측정하는 우식활성검사법과 기존의 우식활성도 측정방법인 dDfFtT rate, Streptococcus mutans colony count와 상관성을 비교, 평가하고, LED 형광법을 이용한 우식활성검사의 특이도, 민감도, 진단력을 평가하였다. 1. LED 형광법을 이용한 우식활성도 측정법은 기존의 Streptococcus mutans colony count 검사법과 비교적 높은 상관관계를 보였다$({\gamma}=0.43,\;P<0.05)$. 2. 육안검사를 기준검사법으로 하였을 때, LED의 특이도, 민감도, 진단력은 각각 100%, 76.1%, 100%이었다. 3. dDfFtT를 기준검사법으로 하였을 때, LED의 특이도, 민감도, 진단력은 각각 88.9%, 47.8%, 95.7%이었다. 4. S. mutans 측정법을 기준검사법으로 하였을 때, LED의 특이도, 민감도, 진단력은 각각 100%, 58.7%, 100%이었다. 이상의 결과를 종합하여 볼 때 LED광중합기를 이용한 광학적 치아우식활성 검사법은 미생물학적 치아우식활성 검사법과 비교하여 유의한 상관관계를 보여 임상에서 활용 가능성이 클 것으로 사료된다.

• 대한치매학회지
• /
• 제23권1호
• /
• pp.11-21
• /
• 2024

Background and Purpose: Although dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, its clinical prevalence is low. We developed a short and easy-to-complete DLB screening questionnaire (DLBSQ) to raise diagnostic sensitivity in routine clinical settings. Methods: A total of 501 participants were retrospectively enrolled, including 71 controls, 184 patients without DLB, and 246 patients with probable DLB. All patients underwent clinical evaluation, including core features of DLB, the DLBSQ, brain magnetic resonance imaging, and detailed neuropsychological assessments. The diagnostic performance of the DLBSQ for probable DLB was investigated using a receiver operating characteristic curve analysis. Results: Total DLBSQ score was associated with visuospatial and frontal/executive dysfunction and the diagnosis of probable DLB. The area under the receiver operating characteristic curve for total DLBSQ score was 0.727. Youden's method revealed an optimal cutoff value of 3. The sensitivity and specificity of the DLBSQ were 68.7% and 62.4%, respectively. Its discriminating performance improved when cognitive test profiles were additionally considered (area under the curve: 0.822, sensitivity: 80.6%, and specificity: 70.4%). Conclusions: The DLBSQ might be a useful screening tool for DLB in routine clinical practice with good sensitivity and specificity.

• 한국전기전자재료학회논문지
• /
• 제22권8호
• /
• pp.704-713
• /
• 2009

As using recruitment phenomenon, SISI test and Bekesy audiometry are employed to differentially diagnose both the cochlear hearing loss and the retrocochlear hearing loss. The main purpose of this study is to find out the sensitivity and specificity of the SISI test within the scope of 1 KHz to 4 KHz in diagnosing various types of hearing losses. In this study, the Bekesy audiometry was conducted for Bekesy audiograms of certain groups according to Jerger's classification, which included persons with normal hearing and patients with hearing impairment. Subject persons of the SISI test were categorized into the several groups with normal hearing, mild hearing loss, moderate hearing loss, moderate-severe hearing loss and severe hearing loss, respectively. The sensitivity and specificity of certain groups were evaluated according to the SISI scores of 20 % below, 25 ${\sim}$ 65 %, and more than 70%. Also, the Bekesy audiometry is conducted on the several subject groups with normal hearing, mixed hearing loss, and sensori-neural hearing loss.